Small Interfering RNA Market Size

Small Interfering RNA Market size is expected to surpass USD 67 Billion by the end of 2036, witnessing around 18.5% CAGR during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of small interfering RNA was USD 13 Billion. The reason behind the growth is impelled by rising cases of cancer across the globe. Small interfering RNA has been studied as an effective treatment for cancer as it targets specific mRNA and blocks abnormal gene expression that causes the disease. By 2040, there will be more than 26 million new instances of cancer worldwide.

The growing partnerships and collaborations are believed to fuel the market growth. For instance, in 2022 Alnylam Pharmaceuticals and Novartis came together to treat liver disease by using siRNA to suppress a Novartis-discovered target, which could lead to the regeneration of functional liver cells and advance the possibility for new drugs in a variety of illness conditions.